Thank you
This live web event has ended. Thank you for attending.
Description
Homologous Recombination
Deficiency (HRD) Testing in
Advanced Ovarian Cancer
Why should you register now for this webinar?
Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenters: Dana Chase, MD, FACOG and Shirley Michelle Shiller, DO, MSPT
You will have the opportunity to ask questions to our distinguished presenters.
CAP TODAY does not endorse any of the products or services named within. This webinar is sponsored by AstraZeneca. ©2020 AstraZeneca. All rights reserved. US-44039 Last Updated 8/20